Cite
APA Citation
Gibbs, J., Grover, A., Emery, M., Dodds, M., Somaratne, R., & Wasserman, S. (2015). impact of target-mediated elimination on evolocumab dose and regimen. Atherosclerosis, 241(1), e197–. http://access.bl.uk/ark:/81055/vdc_100025922209.0x000035